Due to similar links to inflammation, NLRP3 inflammasome activation, and Panx1-related infectious diseases, the proposed group of drugs could hold great potential to uncover additional Panx1 channel inhibitors [93,94,95,96,97,98]. This evidence concerns the gene PANX1 and infectious disease.